Try our Advanced Search for more refined results
Strategic Health Law
-
Notice | Filed: October 24, 2023 | Entered: October 24, 2023 In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation
Personal Inj. Prod. Liability | Kansas
Notice (Other)
NOTICE of Filing of Mylan's Reply in Support of its Motion for Judicial Review by Mylan Specialty, LP, Mylan, Inc. (Himonas, Constandinos)
-
Response | Filed: October 24, 2023 | Entered: October 24, 2023 In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation
Personal Inj. Prod. Liability | Kansas
Reply to Response to Motion
REPLY TO RESPONSE TO MOTION by Plaintiff Sanofi-Aventis US, LLC, Counter Defendant Sanofi-Aventis US, LLC re: 2652 Motion to Retax Costs (Buchweitz, Yehudah)
-
Notice | Filed: October 10, 2023 | Entered: October 10, 2023 In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation
Personal Inj. Prod. Liability | Kansas
Notice (Other)
NOTICE of Filing of Mylan's Response to Sanofi's Motion to Retax Costs by Mylan Specialty, LP, Mylan, Inc. (Himonas, Constandinos)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login